Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -2.63% | 1.11 | 1.13 | 1.10 | 1.12 | 1.14 | 17:59:51 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.10 | 1.14 | 0.04 | 3.51% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 447 | 102,860 | $ 1.11 | $ 114,555 | 203,645 | 0.777212 - 2.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:04:46 | 20 | $ 1.144 | USD |
Moleculin Biotech Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 50.17M | 45.20M | $ -11.88M | -0.46 | - | 43.75M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.01 | 1.28 | 1.01 | 1.10 | 235,232 | 0.10 | 9.9% |
| 1 Month | 1.10 | 1.28 | 1.01 | 1.06 | 166,731 | 0.01 | 0.91% |
| 3 Months | 1.12 | 1.36 | 0.95 | 1.11 | 192,666 | -0.01 | -0.89% |
| 6 Months | 1.45 | 2.64 | 0.95 | 1.47 | 1,140,317 | -0.34 | -23.45% |
| 1 Year | 1.19 | 2.64 | 0.777212 | 1.39 | 815,507 | -0.08 | -6.72% |
| 3 Years | 3.47 | 3.764 | 0.7064 | 1.86 | 813,680 | -2.36 | -68.01% |
| 5 Years | 8.99 | 9.58 | 0.7064 | 1.91 | 727,716 | -7.88 | -87.65% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis. |
